Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Caroline Hartley, a Senior Postdoctoral Research Fellow in the Paediatric Neuroimaging Group, has been awarded the highly competitive Sir Henry Dale Fellowship.

Feet of new born baby under ultraviolet lamp in the incubator

The scheme is a partnership between the Royal Society and the Wellcome Trust, and provides five years of funding for postdoctoral researchers who aim to become independent scientists leading their own groups. Dr Hartley’s research programme is focused on understanding the relationship between apnoeas and brain function in premature infants; it is due to start in 2019.

 

Premature infants often experience apnoeas – cessation of breathing – which can result in decreased oxygen supply to the brain. Yet whether this impacts brain development is unclear. The aim of Caroline's Fellowship is to gain a better understanding of the interaction between brain activity and apnoeas in premature infants in both the immediate and long-term, with the ultimate aim of improving outcomes for prematurely-born children.

 


I am truly honoured to be awarded this Fellowship and very excited to have the opportunity to investigate these fascinating and clinically relevant questions. Current rapid advances in technology will allow me to harness new developments and derive novel tools to obtain a comprehensive picture of preterm development, which I hope will lead to improved treatment for some of the most vulnerable members of our society" - said Dr Hartley.

 

 

 

 

 

 

 

 

 

 

 

 

 

Professor Rebeccah Slater, the head of the Paediatric Neuroimaging Group, commented on the Fellowship: "Caroline's award of a Sir Henry Dale Fellowship is a fantastic personal achievement. Supporting postdocs making the transition to establishing their independent academic careers is one of the most rewarding aspects of my job, and I am delighted that Caroline will remain in our department to further build paediatric neuroscience research at Oxford."

The Department of Paediatrics' ongoing commitment to support early careers researchers has recently been recognised with an Athena SWAN Silver Award. "This fellowship is in recognition of  Caroline’s outstanding scientific contributions at this early stage of what is without a doubt a promising career. In the name of the entire Department of Paediatrics, I wish her the very best" said Professor Georg Hollander, the Head of Department.

Read more about the research of the Paediatric Neuroimaging Group.

Similar stories

Innovation award for Paediatrics researcher to develop new treatments for childhood cancer

Awards & Appointments Haematology

Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.

Professor Matthew Snape named NIHR Senior Investigator

Awards & Appointments Vaccinology

Four academics supported by the NIHR Oxford Biomedical Research Centre have been awarded a prestigious national award, among them Matthew Snape from the Oxford Vaccine Group.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

COVID-19 Research Vaccinology

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK

COVID-19 Research Vaccinology

A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards & Appointments Neuromuscular Diseases

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

Children’s pain ‘swept under the carpet for too long’ – Lancet Commission

Neuroimaging Publication Research

The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.